Bortezomib-inducible long non-coding RNA myocardial infarction associated transcript is an oncogene in multiple myeloma that suppresses miR-29b

Clinical outcomes of patients with multiple myeloma (MM) have almost doubled the overall survival over the last decade owing to the use of proteasome inhibitor such as bortezomib (BTZ). However, some patients with MM develop primary resistance to BTZ, whereas others develop resistance after treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yunfeng, Liu, Xiao, Zhang, Fangrong, Jiang, Siyi, Liu, Jing, Luo, Yanwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456577/
https://www.ncbi.nlm.nih.gov/pubmed/30967527
http://dx.doi.org/10.1038/s41419-019-1551-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456577/
https://www.ncbi.nlm.nih.gov/pubmed/30967527
http://dx.doi.org/10.1038/s41419-019-1551-z

Ejemplares similares